Skip to main content
. 2023 Aug 17;11(8):2289. doi: 10.3390/biomedicines11082289

Table 1.

Demographic and clinical features of STEMI patients.

Variable All
(n = 105)
Follow Up Group (n = 43) p
Age (years) mean ± SD 60.83 ± 12.9 57.81 ± 11.73 0.172 *
Female/Male n/n 29/76 11/32 0.253
Risk factors, n (%)
Hypertension 75 (71.43) 33 (76.74) 0.509
Hypercholesterolemia 23 (11.90) 11 (25.58) 0.631
Current smoker 53 (50.48) 24 (55.81) 0.555
Obesity (BMI > 30 kg/m2) 31 (29.52) 16 (37.21) 0.363
Diabetes mellitus 24 (22.86) 8 (18.6) 0.569
Presentation
CK-MB (U/L) mean ± SD 108.97± 130.3 120.31± 138.8 0.944 **
Time from symptoms onset to reperfusion (hours) 6.3 ± 3.4 6.7 ± 3.7 0.945 **
eGFR, mean ± SD 65.1 ± 23.7 72.6 ± 19.3 0.075 **
Killip Class, n (%)
  1 77 (73.33) 34 (79.07) 0.465
  2 26 (24.76) 9 (20.93) 0.617
  3 1 (0.95) 0 0.522
Burden of CAD, n (%)
  0 1 (0.95) 0 0.522
  1 68 (64.76) 27 (62.79) 0.818
  2 29 (27.62) 13 (30.23) 0.749
  3 6 (5.71) 3 (6.98) 0.772
Complete revascularization n(%)
  0 (incomplete) 8 (7.62) 6 (13.95) 0.230
  1 (complete) 80 (76.19) 32 (74.42) 0.818
  2 (surgical revascularization) 7 (6.67) 1 (2.33) 0.289
  3 (incomplete due to chronic occlusion or small vessels) 9 (8.57) 4 (9.30) 0.889
In-hospital death, n (%) 7 (6.67) - 0.084
Type of infarction, n (%)
Anterior 49 (46.67) 23 (53.49) 0.453
Inferior 51 (48.57) 19 (44.19) 0.624
Other 5 (4.76) 1 (2.33) 0.496

SD—standard deviation; BMI—body max index; CK-MB—Creatine kinase myoglobin binding; CAD—coronary artery disease; eGFR—estimated glomerular filtration rate; * unpaired heteroscedastic Student t-test; ** Mann–Whitney two-tailed test; all other tests are two-tailed Z tests.